Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



Simple Blood Test can Help Diagnose Breast Cancer


 Simple Blood Test can Help Diagnose Breast Cancer

(epharmanews)- According to an article published Online First in the Lancet Oncology, early-stage breast cancer diagnosis and treatment could be improved by a simple blood test, scientists have recently discovered.

This study builds on earlier research that identified tumor cells circulating in the blood of metastatic (spreading) breast cancer contradicting what is generally know that tumors spread through lymphatic system not through blood stream.

Lead researcher, Professor Anthony Lucci from the Department of Surgical Oncology, University of Texas, USA and colleagues tried to find out whether it is possible to discover these tumor cells in the bloodstream of early-stage breast cancer patients, before the spreads to other parts of the body. They also looked at how the presence of tumor cells affected survival rates and progression of the disease.

“These studies identified that both progression-free and overall survival were worse in patients with one or more circulating tumor cells… the growing body of published work, including our study, suggests that assessment of circulating tumor cells might provide important prognostic information in these patients”, according to Professor Lucci.

Researchers looked at 302 patients with operable breast cancer and were able to identify circulating tumor cells (CTCs) in the blood of 24% of the study group. They found that the presence of CTCs accurately predicted both progression-free survival and overall survival, with 15% of the patients who tested positive for CTCs relapsing, and 10% dying during the study period (February 2005 to December 2010), as compared to just 3% and 2%, respectively, of patients who did not test positive for CTCs.   For patients with a higher concentration of CTCs (three or more per 7.5ml of blood), the correlation with survival and progression rates was even more dramatic, with 31% of these patients dying or relapsing during the study period.

It should be noted that researchers are still in the early stage and further research is required before CTCs in blood can be used to guide clinical decision making. The study has only included patients who did not receive preoperative chemotherapy.  Since the effects of chemotherapy on CTC concentration are poorly understood, further research into this will be an important factor in developing CTC analysis into a useful diagnostic tool for early-stage breast cancer.


اضغط هنا للقراءة باللغة العربية

Prepared by: Basel AlJunaidy


Source :

ePharmaNews






Other Comments

Add a comment

You must sign in to use this servcie

Username:
Password:


facebook comments

Forgot your password


sign up

Consultants Corner

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details